Clinical Trial Supplies Market cover

Clinical Trial Supplies Market By Clinical Phases (Phase I, Phase II, Phase III, and Others), Products and Services (Storage & Distribution [Cold Chain Distribution and Non-cold Chain Distribution], Manufacturing, and Supply Chain Management), End-users (Biologics, Medical Device, Pharmaceutical, and Others), Therapeutic Uses (CNS, Cardiovascular, Oncology, Infectious Disease, Metabolic Disorders, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: FB-2269
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 194
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global clinical trial supplies market size is expected to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing number of prevalence in clinical trials and increasing complexities of drug testing.

Clinical Trial Supplies Market summary

Clinical trial supplies include several equipment and tools that are used for clinical research. Nebulizers, infusion pumps, and syringe needles are the most commonly used clinical trial supplies. Rising acceptance of supply chain management system globally is basically due to increasing pressure to reducing research & development cost and rise in the operational supplies. These factors lead to further contribute significantly to the expansion of the total research & development projects and expenditure of biopharmaceutical companies. To lower down the cost of supplies, biopharmaceutical companies are channelizing their supplies to regional and global players, which is helping them to concentrate more on the trial process.

The geographical supply of these trials is significantly shifting from developed nations to emerging countries. The increasing cost and problems in patient admission have led biopharmaceutical companies to shift towards regions such as Latin America, Asia Pacific, Middle East, and Central & Eastern Europe for cost efficiency and quick patient admission. Developing countries also possess greater chronicle disease variation compared to the West, where conventional diseases are growing. The greater chronicle disease variation in the emerging countries are creating lucrative opportunities to biopharmaceutical companies to expand clinical trials for rare diseases.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising number of clinical trials due to increasing demand for drugs and vaccines for various disease are key driving factors of the market.
  • Increasing expansion of bio similar and biologics drugs experiments in drug discovery trials are expected to accelerate the growth of this market.
  • Technology advancement in supply chain management is also expected to lead the growth of the supplies market.
  • Reducing the overall cost of supplies, biopharmaceutical companies are channelizing their supplies to regional and global players. This is expected to fuel the market.
  • High expenditure on clinical trials and cost of equipment installation for clinical practice in developing countries present key challenges, which are expected to hamper the market growth.

Scope of the Report                         

The report on the global clinical trial supplies market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Clinical Trial Supplies  Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Clinical Phases (Phase I, Phase II, Phase III, and Others), Products and Services (Storage & Distribution [Cold Chain Distribution and Non-cold Chain Distribution], Manufacturing, and Supply Chain Management), End-users (Biologics, Medical Device, Pharmaceutical and Others), Therapeutic Uses (CNS, Cardiovascular, Oncology, Infectious Disease, Metabolic Disorders, and Others),

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Pest Control India Services Services;  Almac Group Ltd.; Movianto Deutschland GmbH; PAREXEL International Corporation; Patheon Inc.; Biocair International Ltd.; Sharp Packaging Systems LLC; KLIFO A/S; Catalent Pharma Solutions; and Thermo Fischer Scientific.

Market Segment Insights

Phase I segment is expected to grow at a rapid pace

Based on clinical phases, the global clinical trial supplies market is divided into phase I, phase II, phase III, and others. The phase I segment is expected to expand at a rapid pace during the forecast period due to less population and high capital investment for initial development of clinical experiments globally. However, the phase III segment is anticipated to account for a key share of the market in the coming years as drug development and testing at this stage is more complex and is required a massive investment for research and development to the greater extent.

Clinical Trial Supplies Market phase

Storage & distribution segment is projected to expand at a considerable CAGR

On the basis of products and services, the market is segregated into storage & distribution, manufacturing, and supply chain management. The storage & distribution segment is further classified as cold chain distribution and non-cold chain distribution. The storage & distribution segment is projected to expand at a considerable CAGR during the forecast period owing to increasing number outsource distribution and storage. Meanwhile, the supply chain management segment is anticipated to constitute a key share of the market during the forecast period as major market players are widely focused on giving high emphasis on experienced personnel of chain management.

 Biologics segment is expected to represent a robust growth rate

Based on end-users, the global clinical trial supplies market is divided into biologics, medical device, pharmaceutical, and others. The biologics segment is expected to represent a robust growth rate during the projected period owing to the increased demand for bio similar in both developing and developed countries. On the other hand, the medical device segment is anticipated to exhibit rapid growth during the forecast period due to increase in the research and development activities that require medical equipment.

 Oncology segment is expected to register a high CAGR

On the basis of therapeutic uses, the global clinical trial supplies market is segmented into CNS, cardiovascular, oncology, infectious disease, metabolic disorders, and others. The oncology segment accounted for a key share of the market in 2019 and is expected to register a high CAGR during the forecast period due to tremendous growth in research and development pipeline. Moreover, the rising number of cancer patients globally results in the rapid expansion of oncology that mostly require temperature sensitive distribution. However, the infectious disease segment is anticipated to expand at a rapid pace during the forecast period owing to increasing prevalence of infectious disease especially in developing countries.

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market of North America is anticipated to constitute a key market share in the near future owing to the advanced technology and greater number of clinical trials in the region. The market of Asia Pacific, however, is anticipated to expand at a rapid pace during the forecast period due to diverse population, easy access to patients and low translation cost. Asia Pacific also provides greater economic advantages to biopharmaceutical companies as the government in China and Singapore are constantly providing massive funds to promote biomedical research in the region.

Clinical Trial Supplies Market region

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clinical Trial Supplies Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Clinical Trial Supplies Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Clinical Trial Supplies Market - Supply Chain
  4.5. Global Clinical Trial Supplies Market Forecast
     4.5.1. Clinical Trial Supplies Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Clinical Trial Supplies Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Clinical Trial Supplies Market Absolute $ Opportunity
5. Global Clinical Trial Supplies Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Clinical Trial Supplies Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Clinical Trial Supplies Demand Share Forecast, 2019-2026
6. North America Clinical Trial Supplies Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Clinical Trial Supplies Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Clinical Trial Supplies Demand Share Forecast, 2019-2026
7. Latin America Clinical Trial Supplies Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Clinical Trial Supplies Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Clinical Trial Supplies Demand Share Forecast, 2019-2026
8. Europe Clinical Trial Supplies Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Clinical Trial Supplies Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Clinical Trial Supplies Demand Share Forecast, 2019-2026
9. Asia Pacific Clinical Trial Supplies Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Clinical Trial Supplies Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Clinical Trial Supplies Demand Share Forecast, 2019-2026
10. Middle East & Africa Clinical Trial Supplies Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Clinical Trial Supplies Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Clinical Trial Supplies Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Clinical Trial Supplies Market: Market Share Analysis
  11.2. Clinical Trial Supplies Distributors and Customers
  11.3. Clinical Trial Supplies Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Pest Control India Services
     11.4.2. Almac Group Ltd.
     11.4.3. Movianto Deutschland GmbH
     11.4.4. PAREXEL International Corporation
     11.4.5. Patheon Inc.
     11.4.6. Biocair International Ltd.
     11.4.7. Sharp Packaging Systems LLC
     11.4.8.

Segments Covered in the Report

The global clinical trial supplies market has been segmented on the basis of

Clinical Phases

  • Phase I
  • Phase II
  • Phase III
  • Others

Products and Services

  • Storage & Distribution
    • Cold Chain Distribution
    • Non-cold Chain Distribution
  • Manufacturing
  • Supply Chain Management

End-users

  • Biologics
  • Medical Device
  • Pharmaceutical
  • Others

Therapeutic Uses

  • CNS
  • Cardiovascular
  • Oncology
  • Infectious Disease
  • Metabolic Disorders
  • Others

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Pest Control India Services
  • Almac Group Ltd.
  • Movianto Deutschland GmbH
  • PAREXEL International Corporation
  • Patheon Inc.
  • Biocair International Ltd.
  • Sharp Packaging Systems LLC
  • KLIFO A/S
  • Catalent Pharma Solutions
  • Thermo Fischer Scientific

Key players competing in the global clinical trial supplies market are Pest Control India Services;  Almac Group Ltd.; Movianto Deutschland GmbH; PAREXEL International Corporation; Patheon Inc.; Biocair International Ltd.; Sharp Packaging Systems LLC; KLIFO A/S; Catalent Pharma Solutions; and Thermo Fischer Scientific. These main market players are continuously engaged in various business development activities such as mergers, acquisitions, research and developments, investments for innovative products, and collaborations to expand their consumer base worldwide. For instance, in July 2015 Almac Group Ltd. expanded its supply facility in Singapore to enhance its geographical reach of its products.

Clinical Trial Supplies Market keyplayers

Buy Report